Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Capital Leases (2024 - 2025)

Exagen's Capital Leases history spans 2 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Capital Leases rose 1148.41% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, up 1148.41%, while the annual FY2025 figure was $2.0 million, 1148.41% up from the prior year.
  • Capital Leases reached $2.0 million in Q4 2025 per XGN's latest filing, down from $2.1 million in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $2.1 million in Q3 2025 to a low of $157000.0 in Q4 2024.